LDFO
Inflammatory Skin Disease (unspecified)
Key Facts
About ZoneOne Pharma
ZoneOne Pharma is a clinical-stage biotech leveraging deep expertise in liposomal drug delivery to develop next-generation topical treatments for chronic inflammatory skin disorders. The company's proprietary platform aims to improve drug delivery, efficacy, and patient compliance over existing standards of care. With a leadership team comprised of veterans from the liposomal field, including co-inventors of major approved products like DOXIL and Onivyde, Z1P is advancing a pipeline from preclinical development. The company operates as a private, pre-revenue entity, likely funded through grants and venture capital, and is strategically positioned in the large and growing dermatology therapeutics market.
View full company profile